期刊文献+

血管性痴呆及阿尔茨海默病患者血清甘油三酯和总胆固醇的变化 被引量:2

A Clinical Study on the Serum Triglyceride and Total Cholesterol of Patients with Vascular Dementia and Alzheimer's Disease
原文传递
导出
摘要 目的探讨血管性痴呆(VD)和阿尔茨海默病(AD)患者血清甘油三酯(TG)及总胆固醇(TC)含量的变化和临床意义。方法检测54例血管性痴呆和78例阿尔茨海默病患者血清中TG及TC的含量并与50名正常人对照。结果AD组与VD组血清TG[(1.98±0.98)mmol/L,(2.13±1.01)mmol/L]及TC[(6.52±1.42)mmol/L,(6.36±1.15)mmol/L]均高于对照组[(1.32±0.88)mmol/L,(5.45±0.93)mmol/L],差别有统计学意义(P<0.05),且VD组TG水平与对照组相比,差别有统计学意义(P<0.01),而AD组与VD组之间无统计学意义(P>0.05)。结论AD和VD患者血清TG及TC含量明显增高,降低TG及TC可能对AD和VD的预防和治疗有益。 Objective To explore the change and clinical significance of serum triglycerides and total cholesterol of patients with Vascular dementia (VD) and Atzbeimer's disease (AD). Methods 54 cases of VD and 78 cases of AD were examined. 50 cases of healthy adult were enrolled as the control group. Results The serum triglyceride [(1.98±0.98) mmol/L, (12.13±1.0) mmol/L] in VD patients and total cholesterol [(6.52±1.42 mmol/L, (6.36±1.15) mmol/L] in AD patients were significantly higher than those of the control group [(1.32±0.88) mmoL/L(5.45±0.93) mmoL/L](P〈0.05). There was significant difference in TG between the VD group and the control group (P〈0.01), but there was no difference between the AD and the VD group (P〉0.05). Conclusion The serum triglyceride and total cholesterol of patients with VD and AD were much higher than those of normal healthy persons. It is conducive to lower the triglyceride and total cholesterol for the prevention and treatment of these two diseases.
出处 《中国慢性病预防与控制》 CAS 北大核心 2009年第2期153-154,共2页 Chinese Journal of Prevention and Control of Chronic Diseases
关键词 血管性痴呆 阿尔茨海默病 甘油三酯 总胆固醇 Vascular Dementia Alzheimer's disease Triglyeerides Total cholesterol
  • 相关文献

参考文献7

二级参考文献30

  • 1Town T, Vendrame M, Patel A ,et al. Reduced Th1 and enhanced Th2immunity after immunization with Alzheimer' s beta-amyloid ( 1-42 )[ J ]. J Neuroimmunol,2002,132 ( 1-2 ) :49-59.
  • 2Haugabook S J,Le T,Yager D,et al. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin [J]. FASEB J,2001,15( 1 ) :16-18.
  • 3Beloosesky Y, Salman H, Bergman M, et al. Cytokine levels and phagocytic activity in patients with Alzheimer' s disease [ J ].Gerontology ,2002,48 ( 3 ): 128-132.
  • 4Szczepanik A M, Funes S, Petko W, et al. IL-4, IL-10 and IL-13modulate A beta ( 1-42 ) -induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line [ J ]. J Neuroimmunol,2001,113 ( 1 ) :49-62.
  • 5[1]Shi J, Perry G, Smith MA, et al. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiology of Aging, 2000, 21 (2) :375.
  • 6[2]Kudo T, Imaizumi K, Tanimukai H, et al. Are cerebrovascular factor involved in Alzheimer's disease? Neurobiology of aging, 2000,21 (2): 215.
  • 7[3]M.M.B Breteler. Vascular risk factors for Alzheimers disease: An epidemiology perspective. Neurobiology of Aging, 2000,21 (2): 153.
  • 8[4]Launer L J, White LR, Petrovitch H, et al. Cholesterol and neuropathologic markers of AD. Neurology, 2001,57(8): 1147.
  • 9[5]Shalden MF, Larson EB, Yukawa M. The epidemiology of Alzheimer's disease and vascular dementia in Japanese and Africian-Americian populations: the search for etiological clues. Neurobiology of Aging, 2000,21(2):171.
  • 10[6]Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiology of Aging, 2000,21(2) :321.

共引文献31

同被引文献41

  • 1赵水平,吴军,谭利明,胡治平,肖志杰,聂赛,周宏年,蒋波.他汀类药物对急性脑梗死的抗炎作用[J].中华医学杂志,2005,85(40):2841-2845. 被引量:48
  • 2林岩,李焰生.他汀类药物与痴呆[J].国外医学(脑血管疾病分册),2005,13(9):689-693. 被引量:16
  • 3付剑亮,孙晓江.脂代谢与痴呆[J].国外医学(老年医学分册),2007,28(3):101-104. 被引量:5
  • 4Zhang ZX,Zahner GE,Román GC,et al.Dementia subtypes in China:prevalence in Beijing,Xian,Shanghai,and Chengdu[J].Arch Nenrol,2005,62(3):447-453.
  • 5Hardy J,Seikoe DJ.The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeuties[j].Science,2002,297(5580):353-356.
  • 6Canevari L,Clark JB.Alzheimer's disease and Cholesterol:The Fat Connection[J].Neurochem Res,2007,32(4-5):739-750.
  • 7Kalaria RN,Maestre GE,Arizaga R,et al.World Federation of Neurology Dementia Research Group.Alzheimer's disease and vascular dementia in developing countries:prevalence,management,and risk factors[J].Lancet Nenrol,2008,7 (9):812-826.
  • 8Refolo LM,Malester B,LaFrancois J,et al.Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model[J].Neurobiol Dis,2000,7(4):321-331.
  • 9Qiu C,Winbled B,Fratiglioni L.The age-dependent relation of blood pressure to cognitive function and dementia[J].Lancet Neurol,2005,4(8):487-499.
  • 10Beach TG,Wilson JR,Sue LI,et al.Circle of Willis atherosclerosis:association with Alzheimer's disease,neuritic plaques and neurofibrillary tangles[J].ACTA Neuropathol(Berl),2007,113(1):13-21.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部